NASDAQ:JAGX - Jaguar Health Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$1.70
▼ -0.09 (-5.03%)
1 month | 3 months | 12 months
Get New Jaguar Health Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for JAGX and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for JAGX

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Jaguar Health in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $1.70.

N/A

The current consensus among 0 contributing investment analysts is to n/a stock in Jaguar Health. This rating has held steady since November 2020, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/24/2019
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/23/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/21/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/19/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/18/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/18/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/17/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/16/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/18/2019HC WainwrightReiterated RatingBuy$10.00 ➝ $3.00Low
i
Rating by Vernon Bernardino at HC Wainwright
9/12/2019LADENBURG THALM/SH SHInitiated CoverageBuy$5.00High
i
7/2/2019HC WainwrightSet Price TargetBuy$10.00Low
i
Rating by Vernon Bernardino at HC Wainwright
4/15/2019HC WainwrightReiterated RatingBuyHigh
i
Rating by V. Bernardino at HC Wainwright
7/11/2017HC WainwrightSet Price TargetBuy$2.00High
i
7/11/2017Rodman & RenshawInitiated CoverageBuy ➝ Buy$2.00High
i
(Data available from 6/16/2016 forward)
Jaguar Health logo
Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. It operates through two reportable segments, Human Health and Animal Health. The company, through its subsidiary, Napo Pharmaceuticals, Inc., focuses on developing and commercializing proprietary plant-based human gastrointestinal pharmaceuticals from plants harvested responsibly from rainforest areas. It markets Mytesi, a crofelemer 125 mg delayed-release tablet for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. It develops Mytesi for multiple possible follow-on indications, including diarrhea related to targeted cancer therapy; orphan-drug indications for infants and children with congenital diarrheal disorders and short bowel syndrome; supportive care for inflammatory bowel disease; irritable bowel syndrome; and for idiopathic/functional diarrhea, as well as a second-generation proprietary anti-secretory agent is in development for cholera. The company also develops Crofelemer, a drug product candidate for chemotherapy-induced diarrhea in dogs. Jaguar Health, Inc. was incorporated in 2013 and is headquartered in San Francisco, California.
Read More

Today's Range

Now: $1.70
$1.61
$1.78

50 Day Range

MA: $1.55
$1.16
$2.19

52 Week Range

Now: $1.70
$0.19
$4.47

Volume

13,893,539 shs

Average Volume

25,847,475 shs

Market Capitalization

$237.05 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.49

Frequently Asked Questions

What sell-side analysts currently cover shares of Jaguar Health?

The following Wall Street sell-side analysts have issued stock ratings on Jaguar Health in the last year: Zacks Investment Research.
View the latest analyst ratings for JAGX.

What is the current price target for Jaguar Health?

0 Wall Street analysts have set twelve-month price targets for Jaguar Health in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Jaguar Health in the next year.
View the latest price targets for JAGX.

What is the current consensus analyst rating for Jaguar Health?

Jaguar Health currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for JAGX.

What other companies compete with Jaguar Health?

How do I contact Jaguar Health's investor relations team?

Jaguar Health's physical mailing address is 201 MISSION STREET SUITE 2375, SAN FRANCISCO CA, 94105. The biotechnology company's listed phone number is (415) 371-8300. The official website for Jaguar Health is www.jaguaranimalhealth.com.